<DOC>
	<DOCNO>NCT01034332</DOCNO>
	<brief_summary>We hypothesize one-cycle induction chemotherapy may also help identify chemo-responsive esophageal cancer patient highly treatable definitive CCRT .</brief_summary>
	<brief_title>Paclitaxel/Cisplatin/Fluorouracil Followed Paclitaxel/Cisplatin/Radiotherapy Esophagectomy Esophageal Cancer</brief_title>
	<detailed_description>We hypothesize one-cycle induction chemotherapy may also help identify chemo-responsive esophageal cancer patient highly treatable definitive CCRT.in order test hypothesis , thus propose phase II clinical study verify role `` response one-cycle induction chemotherapy '' prediction pathologic complete response rate CCRT tje outcomes patient loco-regional esophageal cancer .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Pathologically proven esophageal cancer Locally advance disease T3 N01 M0 ; T13 N1 M0 ; T13 N01 M1a Age ≥ 18 year old ECOG ≤ 2 Creatinine &lt; 1.5 mg/dl AST , ALT &lt; 2.5 x upper normal limit Bilirubin &lt; 2.0 mg/dl WBC &gt; 4,000/μl ANC &gt; 2,000/μl Platelet &gt; 100,000//μl Informed consent Invasion surround organ ( T4 disease ) Distant mets ( except M1a ) Prior thoracic irradiation Presence squamous cell carcinoma aerodigestive way Symptomatic comorbid diseases Previous malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Esophageal cancer</keyword>
	<keyword>Esophagectomy</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Induction chemotherapy</keyword>
</DOC>